开发一种干预措施,以改善炎症性肠病男性的性健康评估和护理
Sara Ma1,2, Greg Forshaw3, Mona Kanaan3
1School of Science, Technology and Health, York St John University, York, UK.
Journal of advanced nursing
|September 5, 2025
概括
这项研究共同制作了一种原型干预措施,以帮助护士改善性健康评估和治疗炎症性肠道疾病 (IBD) 的男性. 这项干预旨在解决IBD的忽视问题.
科学领域:
- 胃肠病学
- 性健康问题
- 护理研究
背景情况:
- 炎症性肠病 (IBD) 对男性的性健康和幸福感产生重大影响.
- 在IBD研究和临床实践中经常忽视性健康.
- 护士对评估和解决IBD男性性健康需求的信心很低.
研究的目的:
- 共同制作护士的试验干预措施,以改善IBD男性的性健康评估和护理.
- 解决在此领域支持护士的基于证据的工具的缺口.
- 加强以患者为中心的性保健服务.
主要方法:
- 根据MRC框架进行复杂干预的混合方法研究.
- 对患有IBD的男性,护士和IBD服务的横截面调查.
- 与患者和医疗保健专业人员进行半结构面试,聚焦小组和联合制作研讨会.
主要成果:
- 一个由患者和医疗保健专业人员共同制作的原型干预措施的开发.
- 针对IBD男性的性健康提供现有差距的识别.
- 探索性保健提供可接受和适当的方法.
结论:
- 共同制作的原型干预措施将为护士提供必要的知识和技能.
- 它旨在促进男性IBD患者的性健康的有效评估和以患者为中心的护理.
- 这种干预解决了IBD管理中研究不足的关键领域.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
407
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
407
Inflammatory Bowel Disease V: Surgical Management
200
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
200
Inflammatory Bowel Disease IV: Pharmacological Management
177
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
177
Irritable Bowel Syndrome III: Medical and Nursing Management
286
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
286
Inflammatory Bowel Disease II: Crohn's Disease
370
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236


